KAIGENE Trademark

Trademark Overview


On Monday, June 30, 2025, a trademark application was filed for KAIGENE with the United States Patent and Trademark Office. The USPTO has given the KAIGENE trademark a serial number of 99259208. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, June 30, 2025. This trademark is owned by Kaigene, Inc.. The KAIGENE trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and therapeutic preparations for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Pharmaceutical preparations, namely, a drug formulation using protein degradation for use in treating immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Pharmaceutical and therapeutic preparations for modulating protein degradation pathways; Biochemical preparations for medical use for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Pharmaceutical preparations for targeted protein degradation, comprising small molecules, peptides, biologics, antibodies designed for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Proteins, protein frag...

Chemical preparations for scientific purposes; Molecules for use in industry, namely, protein-modulating molecules for use in the pharmaceutical industry; Molecules for use in science, namely, protein-modulating molecules for use in the pharmaceutical industry; Molecules for molecular biology, other than for medical or veterinary use, namely, protein-modulating molecules for use in the pharmaceutical industry

Research and development in the pharmaceutical and biotechnology fields; Medical and pharmaceutical research services in relation to protein degradation; Providing medical and scientific research information in the field of biochemical, therapeutic, and pharmaceutical preparations; Research and development of platform technology, namely, a biological platform for manufacturing therapeutics for the treatment of autoimmune diseases; Research and development of platform technology, namely, a platform for research and development of pharmaceuticals for the treatment of autoimmune diseases; Development of platform technology, namely, biotherapeutic platforms for use in manufacturing pharmaceuticals and therapeutics; Medical and scientific research, namely, conducting clinical trials for others; Laboratory research services relating to pharmaceuticals; Scientific and technological services, namely, research and design services in the field of process development, validation, qualification, a...
kaigene

General Information


Serial Number99259208
Word MarkKAIGENE
Filing DateMonday, June 30, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, June 30, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical and therapeutic preparations for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Pharmaceutical preparations, namely, a drug formulation using protein degradation for use in treating immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Pharmaceutical and therapeutic preparations for modulating protein degradation pathways; Biochemical preparations for medical use for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Pharmaceutical preparations for targeted protein degradation, comprising small molecules, peptides, biologics, antibodies designed for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Proteins, protein fragments, and protein conjugates all for use in the manufacture of pharmaceutical preparations for treatment of immunologic diseases, particularly autoimmune diseases
Goods and ServicesChemical preparations for scientific purposes; Molecules for use in industry, namely, protein-modulating molecules for use in the pharmaceutical industry; Molecules for use in science, namely, protein-modulating molecules for use in the pharmaceutical industry; Molecules for molecular biology, other than for medical or veterinary use, namely, protein-modulating molecules for use in the pharmaceutical industry
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields; Medical and pharmaceutical research services in relation to protein degradation; Providing medical and scientific research information in the field of biochemical, therapeutic, and pharmaceutical preparations; Research and development of platform technology, namely, a biological platform for manufacturing therapeutics for the treatment of autoimmune diseases; Research and development of platform technology, namely, a platform for research and development of pharmaceuticals for the treatment of autoimmune diseases; Development of platform technology, namely, biotherapeutic platforms for use in manufacturing pharmaceuticals and therapeutics; Medical and scientific research, namely, conducting clinical trials for others; Laboratory research services relating to pharmaceuticals; Scientific and technological services, namely, research and design services in the field of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; Scientific and technological consultation services in the field of development, manufacturing and testing of pharmaceuticals and biopharmaceuticals; Providing product research and development in the pharmaceutical field for purposes of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; Custom development of pharmaceutical and biopharmaceutical products; Providing evaluation testing for pharmaceutical and biopharmaceutical products featuring protein degradation; Pre-clinical and non-clinical evaluation testing of pharmaceutical and biopharmaceutical products; Pharmaceutical and biopharmaceutical research and development featuring protein degradation for others; Pharmaceutical research for the treatment of immunological diseases, inflammatory diseases, neurological diseases, cancer, and other human diseases, and genetic disorders; Medical and pharmaceutical research in relation to targeted therapies that degrade disease driving membrane and extracellular proteins; Testing, inspection, research, or development of pharmaceutical preparations; Providing an on-line searchable database featuring protein molecules for scientific research purposes; Providing on-line non-downloadable software program for use in the discovery and development of targeted proteins used to develop treatments for diseases; Providing on-line non-downloadable software program for use in the discovery and development of targeted proteins used to develop medicines; Providing on-line non-downloadable software program for identifying, searching, and screening protein molecules; Providing on-line non-downloadable software program for searching within a library of protein molecules; Providing medical and scientific research information; Consulting services in the field of genetic science

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateMonday, June 30, 2025
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 30, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 30, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKaigene, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events


Event DateEvent Description
Monday, June 30, 2025NEW APPLICATION ENTERED
Monday, June 30, 2025APPLICATION FILING RECEIPT MAILED